<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T04:52:53Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/10301" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/10301</identifier><datestamp>2026-10-18T21:13:07Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>β-caryophyllene attenuates lead acetate-induced hepatotoxicity through regulation of oxidative stress, inflammation, and PI3K/AKT/mTOR signaling</dc:title><dc:creator>Manavoğlu Kirman, Esra</dc:creator><dc:creator>Bolat, İsmail</dc:creator><dc:creator>Karaarslan, Tuba</dc:creator><dc:creator>Tekin, Samet</dc:creator><dc:creator>Atasever, Aslıhan</dc:creator><dc:subject>Apoptosis</dc:subject><dc:subject>Hepatotoxicity</dc:subject><dc:subject>Lead acetate</dc:subject><dc:subject>Oxidative stress</dc:subject><dc:subject>PI3K/AKT/mTOR signaling</dc:subject><dc:subject>β-Caryophyllene</dc:subject><dc:subject>Animals</dc:subject><dc:subject>Anti-Inflammatory Agents</dc:subject><dc:subject>Antioxidants</dc:subject><dc:subject>Chemical and Drug Induced Liver Injury</dc:subject><dc:subject>Cytokines</dc:subject><dc:subject>Inflammation</dc:subject><dc:subject>Liver</dc:subject><dc:subject>Male</dc:subject><dc:subject>Organometallic Compounds</dc:subject><dc:subject>Phosphatidylinositol 3-Kinase</dc:subject><dc:subject>Phosphatidylinositol 3-Kinases</dc:subject><dc:subject>Polycyclic Sesquiterpenes</dc:subject><dc:subject>Proto-Oncogene Proteins c-akt</dc:subject><dc:subject>Rats</dc:subject><dc:subject>Rats, Sprague-Dawley</dc:subject><dc:subject>Signal Transduction</dc:subject><dc:subject>TOR Serine-Threonine Kinases</dc:subject><dc:subject>antiinflammatory agent</dc:subject><dc:subject>antioxidant</dc:subject><dc:subject>caryophyllene</dc:subject><dc:subject>cytokine</dc:subject><dc:subject>mTOR protein, rat</dc:subject><dc:subject>organometallic compound</dc:subject><dc:subject>phosphatidylinositol 3 kinase</dc:subject><dc:description>Lead acetate (PbAc) is an environmental toxicant known to induce liver injury through oxidative stress, inflammation, and apoptosis. This study aimed to investigate the potential hepatoprotective effects of β-caryophyllene (BCP), a natural sesquiterpene with antioxidant and anti-inflammatory properties, against PbAc-induced hepatotoxicity and to explore the underlying molecular mechanisms. Sixty male Sprague–Dawley rats were randomly assigned to five groups: control, BCP200, PbAc, PbAc + BCP100, and PbAc + BCP200. PbAc was used to induce hepatotoxicity, while BCP was administered at doses of 100 and 200 mg/kg. Serum liver enzymes (ALT, AST, ALP, and GGT), oxidative stress parameters (MDA, SOD, and GSH), and inflammatory cytokines (TNF-α, IL-1β, and IL-6) were evaluated. Immunohistochemical and immunofluorescence analyses were performed to assess Nrf2, HO-1, Sirt1, Keap1, and 8-OHdG expression. In addition, the mRNA expression of PI3K, AKT, mTOR, Bax, Bcl-2, and Caspase-3 was determined by qRT-PCR, and histopathological examinations of liver tissue were conducted. PbAc exposure significantly increased serum liver enzyme levels, lipid peroxidation, and pro-inflammatory cytokines while reducing antioxidant defense markers. It also suppressed Nrf2/HO-1 signaling and PI3K/AKT/mTOR gene expression, accompanied by increased Bax and Caspase-3 and decreased Bcl-2 expression, indicating enhanced apoptosis. Histopathological analysis confirmed severe hepatic degeneration and necrosis. BCP treatment significantly attenuated these alterations by reducing oxidative stress and inflammatory responses, restoring Nrf2/HO-1 signaling, improving PI3K/AKT/mTOR pathway activity, and regulating apoptosis-related gene expression. These findings suggest that β-caryophyllene may exert protective effects against PbAc-induced hepatotoxicity through modulation of oxidative stress, inflammation, cell survival signaling, and apoptosis pathways, highlighting its potential as a supportive therapeutic candidate for heavy metal-induced liver injury. © The Author(s) 2026.</dc:description><dc:publisher>Springer Science and Business Media Deutschland GmbH</dc:publisher><dc:date>2026</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/10301</dc:identifier><dc:identifier>https://doi.org/10.1007/s00210-026-05605-1</dc:identifier><dc:identifier>0028-1298</dc:identifier><dc:language>en</dc:language><dc:relation>Naunyn-Schmiedeberg's Archives of Pharmacology</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/10301</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>